tradingkey.logo
tradingkey.logo
Search

Intellia Therapeutics Inc

NTLA
Add to Watchlist
10.680USD
-0.410-3.70%
Close 07-31 16:00ETQuotes delayed by 15 min
1.49BMarket Cap
LossP/E TTM

NTLA Financials

See Intellia Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Intellia Therapeutics Inc Earnings Date

Latest Release
Aug 6, 2026
EPS / Forecast
--/-0.80
Revenue / Forecast
--/13.90M
Period
FY2025 Earnings
Revenue(YoY)
67.67M
16.92%
EPS(YoY)
-3.81
27.48%
Analyst Rating
HOLD
2026/08/02
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
26.48%-0.81
34.73%-0.83
31.56%-0.92
35.60%-0.98
1.81%-1.10
13.39%-1.27
2.55%-1.34
-8.06%-1.52
4.25%-1.12
-4.68%-1.46
---1.38
---1.40
---1.17
---1.40
---4.78
----
----
----
----
----
Revenue
-9.50%15.05M
78.79%23.02M
51.27%13.78M
104.76%14.24M
-42.54%16.63M
771.57%12.87M
-24.02%9.11M
-48.82%6.96M
129.53%28.93M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
5.59%13.57M
84.15%13.27M
114.20%14.03M
74.58%11.25M
94.91%12.85M
-67.58%7.20M
-59.72%6.55M
Net Profit
15.83%-96.23M
25.69%-95.79M
25.34%-101.32M
31.11%-101.25M
-6.42%-114.33M
2.47%-128.90M
-11.04%-135.71M
-18.83%-146.97M
-4.18%-107.44M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
-92.54%-81.24M
-157.34%-71.64M
-112.41%-68.81M
Net Margin
7.00%-639.49%
58.44%-416.15%
50.64%-735.19%
66.35%-710.81%
-85.19%-687.61%
---1001.23%
-46.15%-1489.54%
-132.20%-2112.62%
54.61%-371.30%
----
---1019.21%
---909.82%
---818.07%
---835.53%
---935.92%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
----
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Revenue
-9.50%15.05M
78.79%23.02M
51.27%13.78M
104.76%14.24M
-42.54%16.63M
771.57%12.87M
-24.02%9.11M
-48.82%6.96M
129.53%28.93M
-114.12%-1.92M
-9.60%11.99M
-3.11%13.59M
12.03%12.61M
5.59%13.57M
84.15%13.27M
114.20%14.03M
74.58%11.25M
94.91%12.85M
-67.58%7.20M
-59.72%6.55M
Operating profit
16.78%-100.53M
27.66%-98.71M
23.00%-111.48M
20.89%-110.00M
-5.97%-120.81M
2.46%-136.45M
-10.42%-144.77M
-5.07%-139.04M
-1.83%-114.00M
-27.07%-139.89M
-24.24%-131.11M
-34.62%-132.33M
22.38%-111.96M
-36.90%-110.09M
-46.58%-105.53M
-42.43%-98.30M
-210.71%-144.25M
-89.66%-80.42M
-156.18%-71.99M
-108.93%-69.02M
Net Profit
15.83%-96.23M
25.69%-95.79M
25.34%-101.32M
31.11%-101.25M
-6.42%-114.33M
2.47%-128.90M
-11.04%-135.71M
-18.83%-146.97M
-4.18%-107.44M
-16.54%-132.16M
-7.94%-122.22M
-22.85%-123.68M
29.79%-103.13M
-39.60%-113.41M
-58.04%-113.23M
-46.32%-100.68M
-217.87%-146.87M
-92.54%-81.24M
-157.34%-71.64M
-112.41%-68.81M
Current assets
-15.41%466.45M
-17.53%527.71M
-18.14%581.94M
-34.50%495.94M
-37.63%551.39M
-35.91%639.86M
-20.44%710.90M
-19.41%757.21M
-8.26%884.04M
-17.95%998.33M
4.02%893.49M
4.93%939.62M
10.09%963.67M
58.17%1.22B
5.42%858.95M
62.98%895.43M
45.63%875.37M
24.78%769.30M
95.74%814.77M
23.08%549.40M
Total current liabilities
-32.11%76.44M
-6.29%103.88M
-11.31%93.73M
-9.13%95.50M
14.99%112.59M
-3.78%110.85M
14.93%105.68M
5.25%105.09M
-5.29%97.91M
-8.97%115.21M
-29.88%91.95M
-19.32%99.85M
-18.02%103.38M
0.57%126.55M
34.40%131.13M
67.33%123.76M
107.75%126.11M
95.84%125.83M
74.65%97.57M
25.06%73.96M
Total assets
-23.06%758.78M
-29.29%842.13M
-21.14%925.27M
-24.56%898.89M
-21.71%986.16M
-8.45%1.19B
-5.63%1.17B
-9.95%1.19B
-11.16%1.26B
-14.42%1.30B
14.65%1.24B
19.17%1.32B
17.88%1.42B
17.43%1.52B
-18.76%1.08B
65.18%1.11B
67.78%1.20B
91.40%1.29B
191.12%1.33B
36.96%672.24M
Total liabilities
-33.17%137.84M
-46.49%170.73M
-16.08%176.85M
-16.71%183.64M
-7.70%206.24M
27.21%319.06M
2.33%210.74M
0.97%220.47M
-1.58%223.45M
-11.85%250.81M
-20.64%205.94M
-5.01%218.35M
-8.83%227.05M
11.92%284.53M
13.89%259.51M
29.56%229.88M
45.62%249.03M
70.33%254.22M
76.73%227.86M
27.42%177.43M
Total equity
-20.38%620.94M
-23.00%671.39M
-22.25%748.42M
-26.34%715.25M
-24.73%779.92M
-16.97%871.96M
-7.21%962.62M
-12.11%971.06M
-12.99%1.04B
-15.01%1.05B
25.75%1.04B
25.48%1.10B
24.86%1.19B
18.78%1.24B
-25.49%824.95M
77.96%880.55M
74.72%953.75M
97.36%1.04B
235.87%1.11B
40.74%494.81M
Net operating income
21.21%-117.35M
18.67%-69.28M
9.36%-76.90M
-71.21%-99.62M
-23.43%-148.93M
8.45%-85.19M
16.32%-84.84M
35.58%-58.19M
-10.37%-120.66M
-3.54%-93.05M
-29.11%-101.38M
-6.15%-90.32M
-37.00%-109.33M
-64.44%-89.87M
-20.77%-78.53M
-60.61%-85.09M
-52.36%-79.80M
-35.86%-54.65M
-127.68%-65.02M
-192.27%-52.98M
Net investment
-29.70%66.31M
-81.83%27.53M
90.39%-741.00K
541.96%106.91M
1498.51%94.33M
229.93%151.56M
-109.70%-7.71M
29.96%-24.19M
104.83%5.90M
252.36%45.94M
66.87%79.50M
-136.22%-34.54M
-357.51%-122.25M
81.05%-30.15M
111.93%47.64M
186.67%95.34M
285.86%47.47M
24.56%-159.12M
-159.37%-399.38M
-64.22%33.26M
Net financing
--33.57M
-14.67%1.98M
39.74%114.86M
-64.48%14.65M
-100.00%0.00
-97.82%2.32M
330.28%82.19M
1539.35%41.25M
2601.13%59.99M
-78.95%106.48M
-20.33%19.10M
-57.32%2.52M
-95.31%2.22M
22082.59%505.76M
-96.41%23.98M
-17.36%5.89M
-19.24%47.32M
-99.03%2.28M
111906.70%668.68M
-94.61%7.13M

FAQs

What is the total revenue of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its total revenue reached 67.67M, with a year-on-year change of 57.88M.

What are the current assets of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its current assets were 527.71M, with a year-on-year change of -17.53.

What are the total assets of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its total assets of Intellia Therapeutics Inc were 842.13M, with a year-on-year change of -29.29.

What are the total liabilities of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its total liabilities of Intellia Therapeutics Inc were 170.73M, with a year-on-year change of -46.49.

What is the total equity of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its total equity of Intellia Therapeutics Inc was 671.39M, with a year-on-year change of -23.00.

What is the net operating income of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its net operating income of Intellia Therapeutics Inc was -440.99M, with a year-on-year change of 17.46.

What is the net investment of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its net investment of Intellia Therapeutics Inc was 228.03M, with a year-on-year change of 81.60.

What is the net financing of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its net financing of Intellia Therapeutics Inc was 131.49M, with a year-on-year change of -29.21.

What is the Earnings Per Share (EPS) of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -3.81, with a year-on-year change of 27.48.

What is the net income of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its net income was -412.69M, with a year-on-year change of 20.49.

What is the net margin of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its net profit margin was -609.85, with a year-on-year change of 31.99.

What is the Return on Equity (ROE) of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -53.48, with a year-on-year change of 0.97.

What is the Return on Assets (ROA) of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -40.60, with a year-on-year change of 2.54.

What is the operating profit of Intellia Therapeutics Inc?

According to Intellia Therapeutics Inc's FY2025 earnings report, its operating profit was -440.99M, with a year-on-year change of 17.46.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.